No retraction, correction or concern found when last checked on Oct 19, 2026.
The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020
Hiroshi Nishiura, Sung-mok Jung, Natalie M. Linton and 6 more
Journal of Clinical Medicine · 2020 · CC BY
Abstract
A cluster of pneumonia cases linked to a novel coronavirus (2019-nCoV) was reported by China in late December 2019. Reported case incidence has now reached the hundreds, but this is likely an underestimate. As of 24 January 2020, with reports of thirteen exportation events, we estimate the cumulative incidence in China at 5502 cases (95% confidence interval: 3027, 9057). The most plausible number of infections is in the order of thousands, rather than hundreds, and there is a strong indication that untraced exposures other than the one in the epidemiologically linked seafood market in Wuhan have occurred.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 19, 2026. Paragraph numbers are ours, so an answer can point at one.
1. Introduction
Since the announcement of a cluster of pneumonia cases of unknown etiology in Wuhan, Hubei Province, China, was made on 31 December 2019, many rapid virological, clinical, and epidemiological research responses have taken place. The causative agent of the pneumonia is suggested to be a novel coronavirus (2019-nCoV) of the same lineage (but genetically distinct) from the coronavirus causing severe acute respiratory syndrome (SARS). Cases in the initial cluster reported a common exposure—a seafood market in Wuhan where wild animals were served at a restaurant—indicating that a point-source zoonotic (animal-to-human) route was likely the main mode of transmission for those cases.
Although early reports from Wuhan stated that (i) there were only tens of cases in the cluster and (ii) no human-to-human transmission was directly observed, the scientific community was alert to the possibility that the novel coronavirus would spread to other geographic locations—including other countries—via direct human-to-human transmission. In early January, the outbreak began to escalate rapidly with hundreds of cases now confirmed along with the presence of a few household clusters.
As of 24 January 2020, the cumulative incidence in China is 830 cases, of which 549 cases were diagnosed in Hubei, 26 in Beijing, 20 in Shanghai, and 53 in Guangdong. Additionally, twenty-six deaths have been linked to the outbreak, and thirteen cases were exported to Japan, Singapore, South Korea, Taiwan, Thailand, Vietnam and the United States as of 22 January 2020. Considering that enhanced surveillance has been underway in these importing countries, case ascertainment has been perhaps better in exported case data.
Using a spatial back-calculation method and analyzing exported cases, we estimate the cumulative incidence of 2019-nCoV cases in China in real time, allowing us to update and discuss the extent of transmission at the source.
2. Exported Cases
Table 1 shows the incidence of exported cases by date of hospitalization and report. Due to the initial difficulty of diagnosis in the absence of established primer for polymerase chain reaction testing, the time lag between hospitalization and reporting was longer for early cases compared with that of more recent cases. Among the seven locations reporting importation, the total volume of inbound passengers from China was m = 63.1 million per year in 2017, of which 100q = 2.1% were from Wuhan, a home of n = 19.0 million people as the catchment population of Wuhan airport. Two other locations with confirmed cases, i.e., Macau and Hong Kong, were excluded from the analysis, because it is commutable by land transporation and the first case in Hong Kong was indeed not via airtravel. As we already know from elsewhere, given the observed cumulative count of c exported cases, we have a balance equation of the cumulative risk of infection: where T is the sum of incubation and infectious periods, and here is assumed to be 3.2 and 9.3 days, respectively, assuming that these periods are similar to those of other coronaviruses, and thus, T = 12.5 days. The estimated incidence in China is then given by. With an ad-hoc assumption that the data are generated following the binomial sampling process among travelers from Wuhan, the cumulative incidence is then estimated using a maximum likelihood method.
Table 1 also shows the estimated incidence in China. The first exportation event in Thailand suggests 423 cases with the upper confidence limit of 1863 cases. The estimated cumulative incidence has grown as additional cases have been reported. As of 24 January 2020, with reports of thirteen exportation events, the cumulative incidence in China is estimated at 5502 cases (95% confidence interval: 3027, 9057).
Our latest estimate is comparable to a preliminary report posted by a research group at Imperial College London (ICL) on their own homepage on 22 January 2020 that estimated the incidence based on three importation events at 4000 cases (95% CI: 1000, 9700). Possible reasons for the slight difference include (i) the number of travelers in the previous study was derived from airline passenger data and (ii) the assumed length of T was different. Two other estimates have also been published: a preliminary study by a Northeastern University group estimated 1250 cases (95% CI: 350, 3000) as of 17 January 2020 and a University of Hong Kong group estimated 1343 cases (95% CI: 547, 3446) as of 17 January 2020. The former study from the United States assumes that the catchment area population is 10 million (we use 11.1 million).
3. The Way Forward
The number of reported 2019-nCoV infections continues to grow as surveillance and detection methods improve. Our estimate and others agree that the actual number of cases is likely in the order of thousands, rather than hundreds, and there is a strong indication that untraced exposures other than that of the originally linked seafood market in Wuhan have occurred. Such exposures are expected to include human-to-human transmission, but the levels of transmissibility have yet to be quantified. It is still plausible that a substantial number of human infections arose from animal-to-human exposures, such as was the case during the first outbreak of highly pathogenic influenza (H7N9) in China, 2013, and the human-to-human transmissibility has yet to be quantified in an explicit manner.
Despite initially restricting what information on the outbreak was shared publicly, the Chinese government has begun to respectfully provide updates on the situation on a daily basis. This encourages the real-time release of information by means of regularly updated situation reports, including epidemiological information with dates of exposure, illness onset, and hospitalization among cases.
For researchers to be able to contribute to control efforts by improving situation awareness via an explicit risk assessment, it is crucial that detailed epidemiological data are posted to a public domain in real-time. Such datasets should include not only a deidentified line list of cases but also updates on the infection status of traced contacts. Information on exposure period and illness onset can assist with the estimation of important natural history parameters such as the incubation period. It is critical for the public health community and the public at large to understand more about the process of case ascertainment, including the current case definition and reporting system mechanisms.
References 29
- 1.
Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181-192.
Not in our library10.1038/s41579-018-0118-9
- 2.
Hui D.S., I Azhar E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., McHugh T.D., Memish Z.A., Drosten C., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020;91:264-266.
Not in our library10.1016/j.ijid.2020.01.009
- 3.
Wuhan Municipal Health Commission. Wuhan Municipal Health Commission’s Briefing on the Current Pneumonia Epidemic in the City. 2020.
Not in our library
- 4.
World Health Organization. Novel Coronavirus—Japan (ex-China). 2020.
Not in our library
- 5.
World Health Organization. Novel Coronavirus—Republic of Korea (ex-China). 2020.
Not in our library
- 6.
World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report—1. 2020.
Not in our library
- 7.
Centers for Disease Control and Prevention. 2019 Novel Coronavirus, Wuhan, China. 2020.
Not in our library
- 8.
CNN-World. Wuhan Coronavirus Death Toll Rises to Nine with 453 Infected Says China, Sparking Fears of Wider Spread. 2020.
Not in our library
- 9.
World Tourism Organization.
Not in our library
- 10.
CEIC, Global Economic Data. 2020.
Not in our library
- 11.
Dorigatti I., Hamlet A., Aguas R., Cattarino L., Cori A., Donnelly C.A., Garske T., Imai N., Ferguson N.M. International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017. Euro. Surveill. 2017;22:30572.
Not in our library10.2807/1560-7917.es.2017.22.28.30572
- 12.
Tsuzuki S., Lee H., Miura F., Chan Y.H., Jung S.-m., Akhmetzhanov A.R., Nishiura H. Dynamics of the pneumonic plague epidemic in Madagascar, August to October 2017. Euro Surveill. 2017;22.
Not in our library10.2807/1560-7917.es.2017.22.46.17-00710
- 13.
Shimizu K., Nishiura H., Imamura A. Investigation of the proportion of diagnosed people living with HIV/AIDS among foreign residents in Japan. J. Clin. Med. 2019;8:804.
Not in our library10.3390/jcm8060804
- 14.
Lessler J., Reich N.G., Brookmeyer R., Perl T.M., Nelson K.E., Cummings D.A.T. Incubation periods of acute respiratory viral infections: A systematic review. Lancet Infect. Dis. 2009;9:291-300.
Not in our library10.1016/s1473-3099(09)70069-6
- 15.
Kanagawa Prefecture. Outbreak of Patients with Pneumonia Associated with Novel Coronavirus. 2020.
Not in our library
- 16.
World Health Organization. Novel Coronavirus—Thailand (ex-China). 2020.
Not in our library
- 17.
Thailand Ministry of Public Health-Bureau of Information Office of the Permanent Secretary of MOPH. Ministry of Public Health Receives 2 Tourists from Wuhan for Pneumonia at Bamrasnaradura Institute. 2020.
Not in our library
- 18.
Kaixian T.V. First Confirmed Case of New Coronavirus Pneumonia in Taiwan. 2020.
Not in our library
- 19.
Washington State Department of Health-News Release. Case of 2019 Novel Coronavirus Confirmed in Washington State Resident. 2020.
Not in our library
- 20.
Reuters-WORLD NEWS. Macau Confirms First Wuhan Virus Case, Tightens Screening in Casinos. 2020.
Not in our library
- 21.
Channel News Asia. Wuhan Virus: 2 More Cases Confirmed in Thailand. 2020.
Not in our library
- 22.
Ministry of Health, Singapore. Confirmed imported case of novel coronavirus infection in Singapore; Multi-ministry taskforce ramps up precautionary measures. 2020.
Not in our library
- 23.
Xinhua News. Vietnam confirms first 2 novel coronavirus cases. 2020.
Not in our library
- 24.
Nikkei News. Novel pneumonia, 2nd case confirmed. Tourist from Wuhan. 2020.
Not in our library
- 25.
Korea Times. South Korea reports 2nd confirmed case of Wuhan coronavirus. 2020.
Not in our library
- 26.
Imperial College London-MRC Centre for Global Infectious Disease Analysis. News/Wuhan Coronavirus. 2020.
Not in our library
- 27.
Bogoch I.I., Watts A., Thomas-Bachli A., Huber C., Kraemer M.U.G., Khan K. Pneumonia of unknown etiology in Wuhan, China: Potential for international spread via commercial air travel. J. Travel Med. 2020.
Not in our library10.1093/jtm/taaa008
- 28.
Northeastern University. Laboratory for the Modeling of Biological and Socio-Technical Systems. 2020.
Not in our library
- 29.
The University of Hong Kong-HKUMed WHO Collaborating Centre for Infectious Disease Epidemiology and Control. 2020.
Not in our library
Cited by papers we hold 13
- Head and neck cancer management in the Covid-19 era: Our experience · 2021Not checked
- Anxiety and Depression Among Health Sciences Students in Home Quarantine During the COVID-19 Pandemic in Selected Provinces of Nepal · 2021Not checked
- The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights · 2020No notice
- Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations · 2020No notice
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review · 2020No notice
- Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data · 2020No notice
- Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China · 2020No notice
- COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge · 2020No notice
- Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV · 2020No notice
- Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China · 2020No notice
- Knowledge, perceptions and preventive practices towards COVID-19 early in the outbreak among Jimma university medical center visitors, Southwest Ethiopia · 2020No notice
- Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases · 2020No notice
- Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.